(continued)
- Sogroya (somapacitan-beco)
- Ngenla (somatrogon-ghla)
- Carvykti (Ciltacabtagene Autoleucel)
- Hyftor (sirolimus)
- Opsynvi (macitentan/tadalafil)
- Pilocarpine ophthalmic
- Saphnelo (anifrolumab)
- Opzelura (ruxolitinib)
- Welireg (belzutifan)
- Tivdak (Tisotumab-Vedotin-Tftv)
- Jemperli (dostarlimab-gxly)
- Onureg (azacitidine)
- Gavreto (pralsetinib)
- Monjuvi (tafasitamab-cxix)
- Mycapssa (Octreotide)
- Dojolvi (triheptanoin)
- Inqovi (decitabine/cedazuridine)
- Tecartus (Brexucabtagene Autoleucel)
- Uplizna (inebilizumab-cdon)
- Koselugo (Selumetinib)
- Tukysa (tucatinib)
- Jelmyto (mitomycin pyelocalyceal)
- Padcev (enfortumab vedotin-ejfv)
- Verkazia (cyclosporine ophthalmic)
- Ayvakit (avapritinib)
- Turalio (Pexidartinib)
- Vyleesi (bremelanotide)
- Nubeqa (darolutamide)
- Rocklatan (netarsudil/latanoprost)
- Mavenclad (cladribine)
- Navigating Psoriasis With Otezla: What You Need to Know
- Navigating Psoriatic Arthritis With Otezla: What You Need to Know
- Myfembree for Uterine Fibroids and Endometriosis
- Caplyta for Schizophrenia and Bipolar Depression